Congress reprises FDA heparin probe; Big pharma lobbies for tougher theft penalties;

> House Republican Fred Upton wants the FDA's documentation from its probe of the 2008 incident of contaminated heparin from China: "There is reason to believe all or some of the individuals responsible for the adulteration are still actively engaged in the Chinese pharmaceutical supply chain." Story

> Abbott Labs, GlaxoSmithKline, J&J and Novo Nordisk have formed a coalition to push for tougher penalties for drug theft. Article

> Purdue Pharma's RxPATROL collaboration has donated $2,500 to the group Silent Witness, increasing the reward for information on a Phoenix heist of 6,200 OxyContin pills. Story

> The Royal Pharmaceutical Society finds Scotland's supply chain "brittle." Story

> Swiss API maker Carbogen Amcis is eliminating 60 of its 350 positions due to restructuring. Carbogen Amcis release

> Pristine Pharma Corp has begun operations at its new Massena, NY-based manufacturing plant  following FDA registration. Pristine release

> The Armenian pharmaceutical industry will apply GMP standards by 2013 to increase drug exports. Story

> Contract manufacturer ScinoPharm has contracted with Clinical Data and will produce vilazodone hydrochloride, the API for the latter's newly approved depression treatment, Viibryd. Story

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.